In 2005 the average American facelift cost $4,484 and a Botox treatment cost $363. Since then the dollar has lost a third of its purchasing power, and the facelift kept pace and then some. It now runs $11,395. Botox costs $435, which is barely a nudge after eighteen years. Adjust for inflation and the most popular cosmetic procedure in America has quietly gotten cheaper. This is the story of how beauty split into two economies. One inflated like a luxury good. The other turned into a commodity.
Put every price on the same starting line in 2005 and let eighteen years run. The facelift bolts early and never looks back. It climbs through the 2008 crash, climbs through COVID, and finishes at more than two and a half times its starting price. Breast augmentation, the signature operation of the era, does something stranger. It hugs the gray inflation line for a decade and then slips underneath it. And Botox, the procedure more Americans buy than any other, wanders sideways like nothing happened. Same industry, same customers, same two decades. Three completely different stories.
Here is the detail that stops you. Rank all seventeen procedures by how much their price grew, and the top four are the four facial surgeries. Not three of four. All four. It makes a certain brutal sense. The face is the one part of the body you cannot cover up, the least forgiving place for a surgeon to be wrong, and the work most concentrated in the hands of the field's most senior names. Injectables now handle the entry level of the face, so the patients still choosing facial surgery are buying the highest stakes craftsmanship in the industry. The price says so.
The whole market in one table. Here is every procedure the ASPS has priced consistently from 2005 through 2023, ranked by how much its sticker price grew. But read the last column, not the first. That number is what remains after you strip out the 56% inflation everyone paid on everything anyway. Most of the middle of this table is really just the cost of living, wearing scrubs. And at the bottom, three procedures did something almost nothing in American life has done since 2005. They got cheaper in real dollars.
| Procedure | 2005 avg fee | 2023 avg fee | Change | Real change |
|---|
So what got cheaper, and why? In real dollars, Botox is down 23% since 2005, hyaluronic acid fillers are down 18%, and breast augmentation is down 8%. Each one is a story about supply. Botox escaped the operating room entirely. There is a med spa in every strip mall now, nurse injectors do most of the work, and four competing brands broke what used to be a monopoly. Fillers followed the same road. Breast augmentation is the field's Model T, its highest volume and most standardized operation, performed so often and by so many surgeons that it behaves like a true competitive market. And the facelift? A facelift is still hours of one senior surgeon's undivided attention. That is the one thing in this entire industry nobody has figured out how to mass produce, so it is the one price that never stopped climbing.
One last way to feel it. Hand the same five thousand dollars to a patient in 2005 and a patient in 2023, and send them both shopping at national-average surgeon fees.
Fees are national average surgeon and physician fees from the American Society of Plastic Surgeons' annual procedural statistics releases, covering 2005 through 2023 and extracted from the original ASPS fee reports. Only procedures with a consistent definition across the whole period are indexed. Categories that were renamed, split or merged are excluded, such as blepharoplasty, which ASPS split into upper and lower eyelid after 2020. Neck lift appears in ASPS data from 2013. ASPS published no statistics report for 2019 or 2021, and it switched from single average fees to fee ranges in 2024, so 2023 is the last directly comparable year. One source anomaly, the 2020 hyaluronic acid filler fee, does not reconcile with its own expenditure figure and was excluded rather than propagated. Inflation adjustment uses BLS CPI-U annual averages of 195.3 for 2005 and 304.7 for 2023. Fees leave out anesthesia, operating room facilities and related costs. From 2023 onward the ASPS fee figures reflect ASPS Member Surgeons only.
Please credit the American Society of Plastic Surgeons for the underlying fee data and NavMDs for this analysis. Journalists: the full year-by-year series behind every chart on this page is available on request via our contact page.